glp 1 agonist and dementia GLP-1 the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential GLP-1s tied to a 'particularly

In June 2025, MBX Biosciences announced that it has submitted an IND application to the FDA for MBX 4291, a long-acting GLP-1/GIP receptor co-agonist prodrug targeting obesity, which received regulatory clearance in July

However, no GLP-1 receptor agonist is currently licensed specifically for treating inflammatory conditions, and there is no definitive evidence establishing superiority of one agent over another for anti-inflammatory purposes

Patients who are forced to switch from a brand name medication at one dose to a compounded version at a different dose may experience a temporary increase in GI side effects as their body adjusts to the new formulation

This background gave Eng both technical expertise and, perhaps more importantly, intellectual permission to pursue unconventional ideas